Autres langues Dynavax Technologies Corporation

Actions

DVAX

US2681582019

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 03/05/2024			Varia. 5j.	Varia. 1 janv.
11,74 ^USD	+0,17%		+4,73%	-16,02%

23/02	Dynavax Technologies annonce des résultats à l'équilibre au 4ème trimestre et une baisse de son chiffre d'affaires	MT
22/02	Transcript : Dynavax Technologies Corporation, Q4 2023 Earnings Call, Feb 22, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Dynavax Technologies : Additional proxy soliciting material – supplement	30/04
Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024	24/04
Dynavax Technologies Corporation Announces Chief Financial Officer Changes	01/04
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference	28/02
Dynavax Technologies Reports Breakeven Q4 Earnings, Lower Revenue	23/02
Dynavax Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Earnings Flash (DVAX) DYNAVAX TECHNOLOGIES Reports Q4 Revenue $55.6M, vs. Street Est of $52.7M	22/02
Dynavax Technologies Corporation Provides Revenue Guidance for the Year 2024	22/02
Dynavax Technologies Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance	22/02
Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024	08/02
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights	08/01
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01
Dynavax Technologies Corporation(NasdaqGS:DVAX) added to NASDAQ Biotechnology Index	18/12
Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference	20/11
Dynavax Technologies Insider Sold Shares Worth $300,000, According to a Recent SEC Filing	07/11
Dynavax Technologies Insider Sold Shares Worth $282,400, According to a Recent SEC Filing	03/11
Dynavax Technologies: Q3 Earnings Snapshot	02/11
Earnings Flash (DVAX) DYNAVAX TECHNOLOGIES Reports Q3 Revenue $69.5M, vs. Street Est of $61.4M	02/11
Dynavax Technologies Corporation Revises Earnings Guidance for the Full Year 2023	02/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Dynavax Technologies Corporation

Actions

DVAX

US2681582019

Autres langues

Filtres